Filing Details
- Accession Number:
- 0001368148-21-000062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-08 17:43:10
- Reporting Period:
- 2021-06-08
- Accepted Time:
- 2021-06-08 17:43:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1368148 | Athersys Inc / New | ATHX | Pharmaceutical Preparations (2834) | 204864095 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1402610 | J John Harrington | 3201 Carnegie Avenue Cleveland OH 44115-2634 | Exec Vice Pres And Cso | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-08 | 27,107 | $1.75 | 672,395 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a previously established and predefined Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.77, inclusive, in accordance with a previously established Rule 10b5-1 trading plan.
- Securities beneficially owned are comprised of (1) 507,138 shares of common stock owned and (2) unvested restricted stock units aggregating 165,257 related to annual awards, which vest quarterly over a three or four-year period from date of grant.
Billionaire Hedge Funds
